Nuvation Bio Inc Capital Reinvestment Ratio
Latest as of March 2026:
0.01x
Nuvation Bio Inc capital reinvestment ratio. Nuvation Bio Inc (NUVB) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow ($5.07 Million) in capital expenditures ($48.00K). Check NUVB total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$5.07 Million
USD
Capital Expenditures
$48.00K
USD
Data as of
Mar 2026
Most recent filing
Nuvation Bio Inc Capital Reinvestment Ratio by Year (None–None)
Nuvation Bio Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see NUVB cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow